Quartet Medicine
400 Technology Square
Cambridge
Massachusetts
02139
United States
Website: http://quartetmedicine.com/
About Quartet Medicine
Quartet Medicine is a private, biotechnology company focused on discovering and developing novel treatments for chronic pain and inflammation. Human genetics and preclinical target validation data point to increased tetrahydrobiopterin (BH4) as a critical mediator of peripheral nerve dysfunction and immune cell regulation. Quartet is capitalizing on these insights by safely restoring BH4 homeostasis in neuronal and inflammatory cells.Quartet was founded by scientists at Boston Children’s Hospital and École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland in conjunction with Atlas Venture. Quartet’s Series A investors include Atlas Venture, Novartis Venture Funds, Pfizer Venture Investments and Partners Innovation Fund. The company is based in Cambridge, Massachusetts and has research efforts underway with collaborators in the US, Europe and Asia.
YEAR FOUNDED:
2013
LEADERSHIP:
CEO: Gerhard Koenig, PhD
CLINICAL TRIAL:
Please click here for clinical trial information.
6 articles about Quartet Medicine
-
Quartet and Cambia Health Solutions Regional Health Plans Team up to Bring Improved Access to Mental Health Care Across the Pacific Northwest
11/27/2019
New Investments from Echo Health Ventures and Deerfield Management Close Out Quartet's Series D Funding Round
-
The company's demise was explained in a blog post by Atlas Venture partner Bruce Booth.
-
Pfizer and Novartis AG-Backed Startup Quartet Medicine Names a New CEO
7/19/2016
-
Merck & Co. and Quartet Medicine Ink Built-To-Buy Deal Worth Up To $575 Million
1/6/2016
-
Quartet Medicine Announces Scientific Advisory Board Comprising Academic And Industry Neuroscience Leaders
5/19/2015
-
Quartet Medicine Launches With $17 Million Series A Financing
10/23/2014